Mission & Values

Navigating what’s next in autoimmune therapy with science of all minds.

Our credo

  • We are a diverse and talented team leveraging trailblazing science to develop paradigm-shifting therapies intended to provide sustained, treatment-free remission and alleviate risks of long-term toxicities to patients living with autoimmune diseases.


  • We are driven by the staggering unmet need for alternatives to existing therapies that may not be effective, or with chronic use that can leave patients susceptible to opportunistic infections and malignancies.


  • We are determined to provide a best-in-class experience to individuals and their caregivers by always adopting a patient-centric approach in everything we do.

Core values

The Bedrock of Our Organization

Bring Intellectual Rigor

We ask thoughtful questions to respectfully advance breakthrough innovations, guide decision-making and deliver measurable, meaningful results.

Elevate Each Other

We own our actions and collaborate with positive intent to advance programmatic initiatives that support our goals.

Stay True to Why

We bring integrity and empathy to our bold mission and collective cause of fulfilling a vast unmet patient need.

Cultural DNA

Kyverna is a different kind of place, where people of diverse scientific, industry, and cultural backgrounds are working together to develop medicines that navigate complex territory – the human immune system. Our mandate is bold: to harness the power of CAR T-cell therapy and create a paradigm shift in the treatment of the underlying cause of autoimmune disease. This requires an interdisciplinary team that brings a range of scientific expertise – synthetic biology, immunology, advanced cell engineering and drug development capabilities – and an appetite for exploring and creating the unknown. Our commitment to employees is to foster an open, supportive, and inclusive environment where we create opportunities for individuals and scientists at every level to learn and grow as people and professionals.

Join us in developing a paradigm shift in the treatment of autoimmune diseases